NK

Nital Kanubhai Patel

Director Director DIN 03641911
DIN 03641911 First appointment Jul 2011 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Nital Kanubhai Patel

Data last updated:

Nital Kanubhai Patel was a Director at Expergen Pharmaceuticals Private Limited (2011) and Director at Enit Tel Services Private Limited (from 2011). The companies operate in Trading.

DIN 03641911
Primary Designation Director
Industry Trading
First Appointment 18 Jul 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jul 20112011₹63,630 (FY 2020)Active
Enit Tel Services Private Limited U74900PN2011PTC141190
Director24 Oct 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Enit Tel Services Private Limited
Expergen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nital Kanubhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nital Kanubhai Patel

Nital Kanubhai Patel was first appointed on 18 Jul 2011 as Director at Expergen Pharmaceuticals Private Limited.

Nital Kanubhai Patel held 2 earlier board appointments: Expergen Pharmaceuticals Private Limited (Director, 18 Jul 2011 to 18 Nov 2011); Enit Tel Services Private Limited (Director, from 24 Oct 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available